Kyle LaHucik, an associate editor covering the gamut of the biotech industry for Endpoints News, has taken on the role of senior reporter to cover venture capital funding, M&A, IPOs and company creation for the financing and business development side of biopharma.
Prior to joining Endpoints, LaHucik was a staff writer at FierceMarkets. Before that, he was a reporter at Mergermarket and interned at Bloomberg, Bloomberg BNA and MLex Market Insight. He was also a newsletter writer at Missouri Business Alert.
He also worked as a public life reporter and education reporter at Columbia Missourian.
LaHucik has a bachelor’s degree in journalism from the University of Missouri-Columbia.
You can congratulate LaHucik on X/Twitter.
